{"id":"W2766928453","doi":"10.1111/jdv.14651","title":"A phase 2a randomized controlled study to evaluate the pharmacokinetic, safety, tolerability and clinical effect of topically applied Umeclidinium in subjects with primary axillary hyperhidrosis","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"Dermira; GlaxoSmithKline","keywords":"Medicine; Tolerability; Clinical endpoint; Randomized controlled trial; Hyperhidrosis; Clinical trial; Adverse effect; Crossover study; Anesthesia; Randomization; Internal medicine; Placebo","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005123067,0.0002190083,0.002779091,0.0001117519,0.0001555509,0.000009117269,0.0003812451,0.0001089686,0.000007067663],"category_scores_gemma":[0.001031953,0.00009389832,0.0002862099,0.00006054506,0.001031929,0.00004736154,0.0002499436,0.0006075219,8.782032e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001563293,"about_ca_system_score_gemma":0.00005870202,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004785724,"about_ca_topic_score_gemma":0.000002759523,"domain_scores_codex":[0.9928359,0.005097691,0.001416278,0.0002291659,0.0002215892,0.0001993248],"domain_scores_gemma":[0.9962556,0.002237438,0.00103612,0.0002866158,0.00006587667,0.0001182934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3359922,0.001409244,0.6544017,0.00007420871,0.001336786,0.0001288179,0.0004497918,0.000003012159,0.00174149,0.00005758,0.00002074796,0.004384435],"study_design_scores_gemma":[0.4589861,0.001363259,0.5327529,0.0001191264,0.00260856,0.001785127,0.0000381837,0.00003500091,0.002118058,0.00006372839,0.00005455847,0.00007539424],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880005,0.0008998946,0.000009298657,0.007815644,0.0001296026,0.001911078,0.000001864534,0.000003645235,0.001228532],"genre_scores_gemma":[0.9984497,0.0006312813,0.00007799307,0.0007188391,0.00007832058,0.00001408581,3.343315e-7,0.00001380007,0.00001565099],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1229939,"threshold_uncertainty_score":0.3829062,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02228269119199282,"score_gpt":0.3575611563178448,"score_spread":0.335278465125852,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}